Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B

Lung-Yi Mak¹

Affiliations

Affiliation

¹ Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China; State Key Laboratory of Liver Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China. Electronic address: loeymak@gmail.com.

PMID: 38901443
DOI: 10.1016/S2468-1253(24)00116-X

Comment

Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B

Lung-Yi Mak. Lancet Gastroenterol Hepatol. 2024 Aug.

. 2024 Aug;9(8):681-682.

doi: 10.1016/S2468-1253(24)00116-X. Epub 2024 Jun 17.

Author

Lung-Yi Mak¹

Affiliation

¹ Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China; State Key Laboratory of Liver Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China. Electronic address: loeymak@gmail.com.

PMID: 38901443
DOI: 10.1016/S2468-1253(24)00116-X

No abstract available

PubMed Disclaimer

Conflict of interest statement

I have served as advisory committee member for Gilead Sciences.

Comment on

Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study.
Janssen HLA, Lim YS, Lampertico P, Heo J, Chen CY, Fournier C, Tsang TYO, Bae H, Chen CH, Coffin CS, Ahn SH, Trinh H, Flaherty JF, Abramov F, Zhao Y, Liu Y, Lau A, German P, Chuang WL, Agarwal K, Gane E. Janssen HLA, et al. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):718-733. doi: 10.1016/S2468-1253(24)00096-7. Epub 2024 Jun 17. Lancet Gastroenterol Hepatol. 2024. PMID: 38901444 Clinical Trial.

References

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B

Affiliation

Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B

Author

Affiliation

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources